Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

44.47
-1.5300-3.33%
Pre-market: 44.780.3100+0.70%09:00 EDT
Volume:923.24K
Turnover:41.57M
Market Cap:3.08B
PE:-11.01
High:45.82
Open:45.68
Low:44.40
Close:46.00
52wk High:71.50
52wk Low:8.73
Shares:69.37M
Float Shares:57.53M
Volume Ratio:0.61
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0399
EPS(LYR):-3.4602
ROE:-157.61%
ROA:-15.72%
PB:9.52
PE(LYR):-12.85

Loading ...

uniQure Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

Goldman Sachs Sticks to Its Hold Rating for uniQure (QURE)

TIPRANKS
·
May 06

Chardan Capital Remains a Buy on uniQure (QURE)

TIPRANKS
·
May 06

Analysts’ Top Healthcare Picks: Spyre Therapeutics (SYRE), uniQure (QURE)

TIPRANKS
·
May 06

Uniqure NV reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Earnings Flash (QURE) UniQure Posts Q1 Net Loss $0.85 a Share, vs. FactSet Est of $0.85 Loss

MT Newswires Live
·
May 05

uniQure Q1 EPS $(0.85), Inline, Sales $3.562M Miss $5.223M Estimate

Benzinga Earnings
·
May 05

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

GlobeNewswire
·
May 05

A Look At uniQure (QURE) Valuation After AMT-130 Regulatory Progress With The MHRA

Simply Wall St.
·
May 04

uniQure Is Maintained at Buy by Chardan Capital

Dow Jones
·
May 01

uniQure price target raised to $37 from $31 at Chardan

TIPRANKS
·
May 01

Update: UniQure Shares Rise After Firm Plans to Submit UK Marketing Application for Huntington's Disease Treatment

MT Newswires Live
·
May 01

uniQure expects UK MHRA filing for AMT-130 in Huntington’s disease in Q3 2026

Reuters
·
Apr 30

uniQure (QURE) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Apr 29

Earning Preview: uniQure NV Q1 revenue is expected to decrease by 16.75%, and institutional views are cautious

Earnings Agent
·
Apr 29

uniQure to Announce First Quarter 2026 Financial Results

GlobeNewswire
·
Apr 28

uniQure call volume above normal and directionally bullish

TIPRANKS
·
Apr 18

uniQure put volume heavy and directionally bearish

TIPRANKS
·
Apr 11

uniQure put volume heavy and directionally bearish

TIPRANKS
·
Apr 08

uniQure (QURE) Faces FDA Rebuke, Lawsuits Over AMT-130 Disclosures Is Its Credibility at Risk?

Simply Wall St.
·
Apr 06